Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 308 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
Q2
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products
View →
Q2
WILLIAMS AND JENSEN, PLLC for PHRMA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Budget/Appropriations, Defense, Trade (domestic/foreign)
View →
Q2
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View →
Q2
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $220,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid
View →
Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice
View →
Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
AARP for AARP
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy, Family issues/Abortion/Adoption
View →
Q2
MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q2
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q2
MARSHALL & POPP, LLC for PFIZER, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q2
MARSHALL & POPP, LLC for GENENTECH, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations
View →
Q2
MARSHALL & POPP, LLC for AMGEN USA INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations
View →
Q2
BIOGEN for BIOGEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark
View →
Q2
LUNDBECK LLC for LUNDBECK LLC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q2
W STRATEGIES, LLC for MERCK & CO., INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid
View →
Q2
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate
Taxation/Internal Revenue Code, Veterans, Tariff (miscellaneous tariff bills), Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q2
DLA PIPER LLP (US) for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q2
THE NICKLES GROUP, LLC for MERCK & CO. INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues
View →
Q2
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income
Pharmacy
View →
Q2
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Previous Page 10 of 13 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem